Eculizumab (Hanya ta Jijiya)

Bkemv, Epysqli, Soliris

Allurar Eculizumab ana amfani da ita wajen magance nau'in cutar jini da ake kira paroxysmal nocturnal hemoglobinuria (PNH). Wannan magani yana taimakawa rage rushewar ƙwayoyin jinin ja ko rushewa (hemolysis) a cikin marasa lafiya masu fama da PNH. Ana kuma amfani da wannan magani wajen magance matsalar koda mai tsanani da ake kira atypical hemolytic uremic syndrome (aHUS). Ana kuma amfani da allurar Eculizumab wajen magance cutar tsoka da jijiya da ake kira generalized myasthenia gravis (gMG) a cikin marasa lafiya da ke da anti-acetylcholine receptor (AchR) antibody mai kyau. Ana kuma amfani da allurar Eculizumab wajen magance cutar neuromyelitis optica spectrum disorder (NMOSD), wacce cuta ce da ba ta da yawa wacce ke haifar da kumburi a jijiyoyin idanu da kashin baya. Ana amfani da ita a cikin marasa lafiya da ke da anti-aquaporin-4 (AQP4) antibody mai kyau. Allurar Eculizumab ƙwayar cuta ce ta monoclonal wacce ke aiki akan tsarin garkuwar jiki. Wannan magani yana samuwa ne kawai ƙarƙashin shirin rarraba da aka yi ƙuntatawa wanda ake kira Ultomiris® da Soliris® REMS (Risk Evaluation and Mitigation Strategy) Program. Wannan samfurin yana samuwa a cikin nau'ikan magunguna masu zuwa:

Wajibi ne a auna haɗarin shan magani da amfanin da zai yi kafin a yi amfani da shi. Wannan yanke shawara ce da kai da likitank za ku yi. Ga abubuwan da ya kamata a yi la'akari da su game da wannan magani: Ka gaya wa likitank idan ka taɓa samun wata illa ta musamman ko rashin lafiyar jiki ga wannan magani ko wasu magunguna. Haka kuma ka gaya wa ƙwararren kiwon lafiyarka idan kana da wasu nau'ikan rashin lafiyar jiki, kamar abinci, dyes, masu kiyayewa, ko dabbobi. Ga samfuran da ba a sayar da su ba tare da takardar sayarwa ba, karanta lakabin ko sinadaran kunshin a hankali. Nazarin da aka yi har zuwa yau bai nuna matsaloli na musamman ga yara da za su iyakance amfanin allurar eculizumab wajen magance cutar hemolytic uremic syndrome mara kyau a jikin yara ba. Duk da haka, ba a tabbatar da aminci da ingancin allurar eculizumab wajen magance wasu cututtuka a jikin yara ba. Nazarin da aka yi har zuwa yau bai nuna matsaloli na musamman ga tsofaffi da za su iyakance amfanin allurar eculizumab ga tsofaffi ba. Babu cikakkun nazarin mata don tantance haɗarin jariri lokacin amfani da wannan magani yayin shayarwa. Auna fa'idodin da za a iya samu da haɗarin da za a iya samu kafin shan wannan magani yayin shayarwa. Ko da yake ba a yi amfani da wasu magunguna tare ba, a wasu lokuta ana iya amfani da magunguna daban-daban tare ko da haɗuwa na iya faruwa. A irin waɗannan lokuta, likitank na iya son canza kashi, ko kuma wasu matakan kariya na iya zama dole. Lokacin da kake karɓar wannan magani, yana da matukar muhimmanci cewa ƙwararren kiwon lafiyarka ya san idan kana shan kowane daga cikin magungunan da aka jera a ƙasa. An zaɓi hulɗar da ke ƙasa bisa ga muhimmancinsu kuma ba lallai ba ne duka. Amfani da wannan magani tare da kowane daga cikin magungunan da ke ƙasa ba a saba ba, amma ana iya buƙata a wasu lokuta. Idan an rubuta magunguna biyu tare, likitank na iya canza kashi ko yadda ake amfani da ɗaya ko duka magungunan. Ba a yi amfani da wasu magunguna a lokacin ko kusa da lokacin cin abinci ko cin wasu nau'o'in abinci ba saboda haɗuwa na iya faruwa. Amfani da barasa ko taba tare da wasu magunguna na iya haifar da haɗuwa. Tattauna da ƙwararren kiwon lafiyarka game da amfani da maganinka tare da abinci, barasa, ko taba. Kasancewar wasu matsalolin lafiya na iya shafar amfani da wannan magani. Tabbatar ka gaya wa likitank idan kana da wasu matsalolin lafiya, musamman: